Contact

All Stories

  1. Tau protein aggregation associated with SARS-CoV-2 main protease

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Dr. Raphael Eberle

  2. The Importance of Epigallocatechin as a Scaffold for Drug Development against Flaviviruses

    Article • Pharmaceutics, March 2023, MDPI AG

    Dr. Raphael Eberle

  3. Discovery of All-d-Peptide Inhibitors of SARS-CoV-2 3C-like Protease

    Article • ACS Chemical Biology, January 2023, American Chemical Society (ACS)

    Dr. Raphael Eberle

  4. A Review of Omics Studies on Arboviruses: Alphavirus, Orthobunyavirus and Phlebovirus

    Article • Viruses, October 2022, MDPI AG

    Dr. Raphael Eberle

  5. Riboflavin, a Potent Neuroprotective Vitamin: Focus on Flavivirus and Alphavirus Proteases

    Article • Microorganisms, June 2022, MDPI AG

    Dr. Raphael Eberle

  6. Discovery of all-D-peptide inhibitors of SARS CoV 2 3C-like protease

    Article • June 2022, American Chemical Society (ACS)

    Dr. Raphael Eberle

  7. Design of D-Amino Acids SARS-CoV-2 Main Protease Inhibitors Using the Cationic Peptide from Rattlesnake Venom as a Scaffold

    Article • Pharmaceuticals, April 2022, MDPI AG

    Dr. Raphael Eberle

  8. The Secreted Metabolome of Hela Cells under Effect of Crotamine, a Cell-Penetrating Peptide from a Rattlesnake Using NMR-Based Metabolomics Analyses

    Article • BioMed, April 2022, MDPI AG

    Dr. Raphael Eberle

  9. A Computer-Aided Approach for the Discovery of D-Peptides as Inhibitors of SARS-CoV-2 Main Protease

    Article • Frontiers in Molecular Biosciences, January 2022, Frontiers

    Dr. Raphael Eberle

  10. The secreted metabolome of HeLa cells under effect of Crotamine, a cell-penetrating peptide from a rattlesnake using NMR-based metabolomics analyses

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Dr. Raphael Eberle

  11. Review of -omics studies on mosquito-borne viruses of the Flavivirus genus

    Article • Virus Research, January 2022, Elsevier

    Dr. Raphael Eberle

  12. Design of D-amino acids SARS-CoV-2 Main protease inhibitors using the cationic peptide from rattlesnake venom as a scaffold

    Article • November 2021, Cold Spring Harbor Laboratory Press

    Dr. Raphael Eberle

  13. Promising Natural Compounds against Flavivirus Proteases: Citrus Flavonoids Hesperetin and Hesperidin

    Article • Plants, October 2021, MDPI AG

    Dr. Raphael Eberle

  14. Novel inhibitors of the main protease enzyme of SARS-CoV-2 identified via molecular dynamics simulation-guided in vitro assay

    Article • Bioorganic Chemistry, June 2021, Elsevier

    Dr. Raphael Eberle

  15. The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro

    Article • Viruses, May 2021, MDPI AG

    Dr. Raphael Eberle

  16. Citrus plant flavonoids with antiviral potential

    Article • PLoS ONE, March 2021, PLOS

    Dr. Raphael Eberle

  17. In silico investigation of Aedes aegypti male-determining factor (NIX): RNA recognition motif-3, structural model and selective nucleic acid binding mode

    Article • November 2020, Cold Spring Harbor Laboratory Press

    Dr. Raphael Eberle

  18. The repurposed drugs suramin and quinacrine inhibit cooperatively in vitro SARS-CoV-2 3CLpro

    Article • November 2020, Cold Spring Harbor Laboratory Press

    Dr. Raphael Eberle

  19. Novel Inhibitors of the Main Protease of SARS-CoV-2 Identified via a Molecular Dynamics Simulation-Guided in Vitro Assay

    Article • November 2020, American Chemical Society (ACS)

    Dr. Raphael Eberle

  20. Novel Inhibitors of the Main Protease of SARS-CoV-2 Identified via a Molecular Dynamics Simulation-Guided in Vitro Assay

    Article • November 2020, American Chemical Society (ACS)

    Dr. Raphael Eberle

  21. A comparative pan-genomic analysis of 53 C. pseudotuberculosis strains based on functional domains

    Article • Journal of Biomolecular Structure and Dynamics, August 2020, Taylor & Francis

    Dr. Raphael Eberle

  22. Binding studies of a putative C. pseudotuberculosis target protein from Vitamin B12 Metabolism

    Article • Scientific Reports, April 2019, Springer Science + Business Media

    Dr. Raphael Eberle

  23. The polyanions heparin and suramin impede binding of free adenine to a DNA glycosylase from C. pseudotuberculosis

    Article • International Journal of Biological Macromolecules, December 2018, Elsevier

    Dr. Raphael Eberle

  24. Inhibition of thioredoxin A1 from Corynebacterium pseudotuberculosis by polyanions and flavonoids

    Article • International Journal of Biological Macromolecules, October 2018, Elsevier

    Dr. Raphael Eberle, Ljubica Tasic

  25. Modeling and molecular dynamics indicate that snake venom phospholipase B-like enzymes are Ntn-hydrolases

    Article • Toxicon, October 2018, Elsevier

    Dr. Raphael Eberle

  26. Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition-

    Article • Antiviral Research, October 2018, Elsevier

    Dr. Raphael Eberle

  27. Biochemical and biophysical characterization of a mycoredoxin protein glutaredoxin A1 from Corynebacterium pseudotuberculosis

    Article • International Journal of Biological Macromolecules, February 2018, Elsevier

    Dr. Raphael Eberle, Ljubica Tasic

  28. Structure and interaction of Corynebacterium pseudotuberculosis cold shock protein A with Y-box single-stranded DNA fragment

    Article • European Journal of Biochemistry, December 2017, Wiley

    Dr. Raphael Eberle

  29. Cold Shock Protein A from Corynebacterium pseudotuberculosis: Role of Electrostatic Forces in the Stability of the Secondary Structure

    Article • Protein and Peptide Letters, March 2017, Bentham Science Publishers

    Dr. Raphael Eberle

  30. Corrigendum to “Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD)” [Acta Trop. 124 (2012) 15–26]

    Article • Acta Tropica, September 2016, Elsevier

    Dr. Raphael Eberle

  31. Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression

    Article • Microbial Cell Factories, May 2016, Springer Science + Business Media

    Dr. Raphael Eberle

  32. Structure of ThiM from Vitamin B1 biosynthetic pathway of Staphylococcus aureus – Insights into a novel pro-drug approach addressing MRSA infections

    Article • Scientific Reports, March 2016, Springer Science + Business Media

    Dr. Raphael Eberle

  33. High resolution structures of Plasmodium falciparum GST complexes provide novel insights into the dimer–tetramer transition and a novel ligand-binding site

    Article • Journal of Structural Biology, September 2015, Elsevier

    Dr. Raphael Eberle

  34. Expression, purification and characterization of cold shock protein A of Corynebacterium pseudotuberculosis

    Article • Protein Expression and Purification, August 2015, Elsevier

    Dr. Raphael Eberle

  35. Preparation and Characterization of Monomodal Grapevine Virus A Capsid Protein

    Article • Protein and Peptide Letters, July 2015, Bentham Science Publishers

    Professor Raghuvir K Arni, Dr. Raphael Eberle

  36. Chemical and thermal influence of the [4Fe–4S]2+ cluster of A/G-specific adenine glycosylase from Corynebacterium pseudotuberculosis

    Article • Biochimica et Biophysica Acta (BBA) - General Subjects, February 2015, Elsevier

    Dr. Raphael Eberle

  37. Isolation, identification and functional profile of excretory–secretory peptides from Onchocerca ochengi

    Article • Acta Tropica, February 2015, Elsevier

    Dr. Raphael Eberle

  38. Functional characterization and immune recognition of the extracellular superoxide dismutase from the human pathogenic parasite Onchocerca volvulus (OvEC-SOD)

    Article • Acta Tropica, October 2012, Elsevier

    Dr. Raphael Eberle

  39. The secretome of parasitic nematodes: analysis of host-parasite cross-talk

    Article • Acta Crystallographica Section A Foundations of Crystallography, August 2010, International Union of Crystallography

    Dr. Raphael Eberle